Iga, K.
Simulation of Plasma Level Changes in Cerivastatin and Its Metabolites, Particularly Cerivastatin Lactone, Induced by Coadministration with CYP2C8 Inhibitor Gemfibrozil, CYP3A4 Inhibitor Itraconazole, or Both, Using the Metabolite-Linked Model. Drugs Drug Candidates 2025, 4, 34.
https://doi.org/10.3390/ddc4030034
AMA Style
Iga K.
Simulation of Plasma Level Changes in Cerivastatin and Its Metabolites, Particularly Cerivastatin Lactone, Induced by Coadministration with CYP2C8 Inhibitor Gemfibrozil, CYP3A4 Inhibitor Itraconazole, or Both, Using the Metabolite-Linked Model. Drugs and Drug Candidates. 2025; 4(3):34.
https://doi.org/10.3390/ddc4030034
Chicago/Turabian Style
Iga, Katsumi.
2025. "Simulation of Plasma Level Changes in Cerivastatin and Its Metabolites, Particularly Cerivastatin Lactone, Induced by Coadministration with CYP2C8 Inhibitor Gemfibrozil, CYP3A4 Inhibitor Itraconazole, or Both, Using the Metabolite-Linked Model" Drugs and Drug Candidates 4, no. 3: 34.
https://doi.org/10.3390/ddc4030034
APA Style
Iga, K.
(2025). Simulation of Plasma Level Changes in Cerivastatin and Its Metabolites, Particularly Cerivastatin Lactone, Induced by Coadministration with CYP2C8 Inhibitor Gemfibrozil, CYP3A4 Inhibitor Itraconazole, or Both, Using the Metabolite-Linked Model. Drugs and Drug Candidates, 4(3), 34.
https://doi.org/10.3390/ddc4030034